BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2799693)

  • 1. [Differential diagnosis of osteomalacia and other forms of renal osteodystrophy in terminal renal failure by dynamic scintigraphy with diphosphonate].
    Novikov AI; Ermolenko AE; Ermakova IP; Baeva LB; Levitskiĭ ER
    Ter Arkh; 1989; 61(6):105-9. PubMed ID: 2799693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamic scintigraphy with sodium 1-hydroxy-ethane-1,1 diphosphonate for the differential diagnosis of osteomalacia in patients in the terminal stage of chronic kidney failure].
    Novikov AI; Ermolenko AE; Ermakova IP; Baeva LB; Levitskiĭ ER
    Urol Nefrol (Mosk); 1990; (2):11-5. PubMed ID: 2114687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis of osteomalacia using dynamic scintigraphy with diphosphonate in terminal renal insufficiency].
    Novikov AI; Ermolenko AE; Ermakova IP; Baeva LB; Levitskiĭ ER; Ivanov AE
    Med Radiol (Mosk); 1989 Oct; 34(10):21-7. PubMed ID: 2811623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlations between osteodensitometry and parameters of uremic osteodystrophy].
    Sforzini S; Viganò MR; Beretta P; Rosa M; d'Amico P; Lomuscio G; Paesani R
    Minerva Med; 1985 Mar; 76(9-10):445-8. PubMed ID: 3982703
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of renal failure and metabolic diseases upon bone scanning in children.
    Schümichen C
    Ann Radiol (Paris); 1983; 26(6):498-504. PubMed ID: 6316830
    [No Abstract]   [Full Text] [Related]  

  • 6. Common bone features in osteomalacia, secondary hyperparathyroidism, and renal osteodystrophy.
    Verlooy H; De Roo M; Mortelmans L; Dequeker J
    Clin Nucl Med; 1991 May; 16(5):372-4. PubMed ID: 2054996
    [No Abstract]   [Full Text] [Related]  

  • 7. [X-ray features of fibrous osteodystrophy and osteomalacia in patients with chronic renal insufficiency under present-day treatment].
    Ratobylskiĭ GV; Rassokhin BM; Lanskaia IM; Andrianova MIu
    Ter Arkh; 1987; 59(8):103-7. PubMed ID: 3317968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical x-ray criteria for a differential approach to the surgical treatment of uremic osteodystrophy].
    Filiptsev PIa; Ratobyl'skiĭ GV; Suslov VP; Ivanov IA; Loseva TV
    Urol Nefrol (Mosk); 1993; (1):37-42. PubMed ID: 7941125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiological manifestations of uremic osteodystrophy].
    Meneghello A; Bertoli M; Naso A; Gasparotto ML; Presacco D; Poli I; Rebeschini M; Favaro P; Camposampiero A; Ruffatti AM; Romagnoli GF
    G Clin Med; 1980 Feb; 61(2):98-118. PubMed ID: 6778753
    [No Abstract]   [Full Text] [Related]  

  • 10. Value of the 99mTc-methylene diphosphonate bone scan in renal osteodystrophy.
    Karsenty G; Vigneron N; Jorgetti V; Fauchet M; Zingraff J; Drüeke T; Cournot-Witmer G
    Kidney Int; 1986 May; 29(5):1058-65. PubMed ID: 3723927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance of bone scanning with Tc 99m in the supervision of hemodialysis patients with chronic renal failure (author's transl)].
    Kessler M; Ferry JP; Naoun A; Robert J; Huriet C
    Nephrologie; 1981; 2(4):171-5. PubMed ID: 7329502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiologic study of renal osteodystrophy].
    Bilbao JI; Villaró J; San Julián M; Purroy A
    Rev Med Univ Navarra; 1982 Dec; 26(4):229-37. PubMed ID: 7182894
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bone gammagraphy in the diagnosis of uremic renal osteodystrophy].
    Marco Franco JE; Alarcón Zurita A; Peñafiel A; Pizá Buñola C; Morey Molina A; Bestard Palmer J; Mairata Bosch S; Dalmau Diana M
    Rev Clin Esp; 1982 Mar; 164(5):329-32. PubMed ID: 7100549
    [No Abstract]   [Full Text] [Related]  

  • 14. Diphosphonates in the evaluation of metabolic bone disease.
    Fogelman I; Smith ML
    Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical assessment of the relationship between bone scintigraphy and serum biochemical markers in hemodialysis patients.
    Kurata S; Ishibashi M; Nishida H; Hiromatsu Y; Hayabuchi N
    Ann Nucl Med; 2004 Sep; 18(6):513-8. PubMed ID: 15515752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone scintigraphy in evaluation of the effect of renal transplantation in patients with renal osteodystrophy].
    Seto K
    Rinsho Hoshasen; 1989 Nov; 34(12):1433-6. PubMed ID: 2593286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone scan appearance of renal osteodystrophy in diabetic chronic renal failure patients.
    So Y; Hyun IY; Lee DS; Ahn C; Chung JK; Kim S; Lee MC; Lee JS; Koh CS
    Radiat Med; 1998; 16(6):417-21. PubMed ID: 9929141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The bony scan at 99m Tc pyrophosphate in the chronic kidney deficiency treated by hemodialysis (author's transl)].
    Cledes J; Paille R; Jacolot G; Morin JF; Caroff J
    Sem Hop; 1980 Jan 8-15; 56(1-2):7-10. PubMed ID: 6244634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiophosphate imaging and bone densitometry in renal osteodystrophy.
    Rosenthall L
    Curr Opin Nephrol Hypertens; 1993 Nov; 2(6):956-61. PubMed ID: 7922239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis of renal osteodystrophy: a comparison of Technetium-99m-pyrophosphate bone scintigraphy with other techniques.
    Hodson EM; Howman-Giles RB; Evans RA; Bautovich G; Hills EE; Sherbon K; Bach BD; Horvath JS; Tiller DJ
    Clin Nephrol; 1981 Jul; 16(1):24-8. PubMed ID: 6268343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.